Idexx Laboratories, Inc (NASDAQ:IDXX) shares, rose in value on Friday, May 09, with the stock price up by 0.35% to the previous day’s close as strong demand from buyers drove the stock to $491.70.
Actively observing the price movement in the last trading, the stock closed the session at $489.98. The PE ratio was 45.43 over 12-month period. Referring to stock’s 52-week performance, its high was $548.88, and the low was $356.14. On the whole, IDXX has fluctuated by 23.82% over the past month.
With the market capitalization of Idexx Laboratories, Inc currently standing at about $39.54 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IDXX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 3.43, with the price of IDXX currently trading nearly 11.61% and 15.36% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 73.26, while the 7-day volatility ratio is showing 2.69% which for the 30-day chart, stands at 3.18%. Furthermore, Idexx Laboratories, Inc (IDXX)’s beta value is 1.52, and its average true range (ATR) is 15.51.
A comparison of Idexx Laboratories, Inc (IDXX) with its peers suggests the former has fared considerably weaker in the market. IDXX showed an intraday change of 0.35% in last session, and over the past year, it grew by 1.66%%.
Data on historical trading for Idexx Laboratories, Inc (NASDAQ:IDXX) indicates that the trading volumes over the past 3 months, they’ve averaged 876.81K. According to company’s latest data on outstanding shares, there are 80.74 million shares outstanding.
Nearly 1.03% of Idexx Laboratories, Inc’s shares belong to company insiders and institutional investors own 92.99% of the company’s shares. The stock has risen by 18.93% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IDXX stock heading into the next quarter.
